In today's episode, we uncover the hidden crisis in the pharmaceutical industry as we explore the alarming state of R&D productivity. Our guest, Dr. Jack Scannell, is a renowned scientist and entrepreneur with extensive experience in both the biotech and investment fields. He shares his valuable insights into the concept of Eroom's Law, which reveals the inverse relationship between input efficiency and output efficiency in drug research and development.
Listen in as we discuss the challenges of measuring R&D productivity and how financial return and number of drugs approved per unit input serve as key indicators of productivity. Dr. Scannell helps us understand the reasons behind the decline in R&D productivity since the 1950s and the factors that have contributed the most to this concerning trend.
Don't miss this enlightening conversation that exposes the harsh reality of pharmaceutical R&D productivity, and be sure to share your thoughts and opinions by leaving a review or engaging with us on social media. We'd love to hear from you!
Stay informed on the latest developments in pharmaceutical R&D productivity and other pressing global challenges by subscribing to our podcast. Your support helps us continue to bring you thought-provoking discussions and expert insights.
Link to full episode
01:00 Jack Scannell Explains Eroom's Law
💡 LINKS TO MORE CONTENT
If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribe
Watch on Youtube
Do you want to support the podcast team?
Join the LSG2G Newsletter as a paying member: Link